Compare NVNI & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NVNI | VVOS |
|---|---|---|
| Founded | 2019 | 2016 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.4M | 17.4M |
| IPO Year | N/A | 2020 |
| Metric | NVNI | VVOS |
|---|---|---|
| Price | $1.62 | $1.54 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.25 |
| AVG Volume (30 Days) | ★ 165.1K | 138.2K |
| Earning Date | 09-30-2025 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $36,577,595.00 | $17,317,000.00 |
| Revenue This Year | $6.67 | $28.86 |
| Revenue Next Year | $26.67 | $48.70 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 14.38 | ★ 18.76 |
| 52 Week Low | $1.43 | $1.42 |
| 52 Week High | $40.50 | $7.95 |
| Indicator | NVNI | VVOS |
|---|---|---|
| Relative Strength Index (RSI) | 33.31 | 36.90 |
| Support Level | $1.43 | $1.42 |
| Resistance Level | $1.85 | $1.88 |
| Average True Range (ATR) | 0.20 | 0.14 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 25.73 | 21.14 |
Nvni Group Ltd is a holding company that conducts all of its business through Nuvini SA and Nuvini acquired companies. Nuvini S.A. acquires and operates software companies within SaaS markets in Brazil. Nuvini S.A. is the private serial software business acquirer in Brazil and intends to use funding and capital markets access to continue expanding its acquisition plans in Brazil and Latin America. The Company has determined that it has a single operating and reportable segment which is multi-vertical SaaS solution model.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.